Your browser doesn't support javascript.
loading
Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells.
Klawitter, Sabine; Fuchs, Nina V; Upton, Kyle R; Muñoz-Lopez, Martin; Shukla, Ruchi; Wang, Jichang; Garcia-Cañadas, Marta; Lopez-Ruiz, Cesar; Gerhardt, Daniel J; Sebe, Attila; Grabundzija, Ivana; Merkert, Sylvia; Gerdes, Patricia; Pulgarin, J Andres; Bock, Anja; Held, Ulrike; Witthuhn, Anett; Haase, Alexandra; Sarkadi, Balázs; Löwer, Johannes; Wolvetang, Ernst J; Martin, Ulrich; Ivics, Zoltán; Izsvák, Zsuzsanna; Garcia-Perez, Jose L; Faulkner, Geoffrey J; Schumann, Gerald G.
Afiliação
  • Klawitter S; Division of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225 Langen, Germany.
  • Fuchs NV; Division of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225 Langen, Germany.
  • Upton KR; Max-Delbrück-Center for Molecular Medicine, D-13125 Berlin, Germany.
  • Muñoz-Lopez M; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, Brisbane, Queensland 4102, Australia.
  • Shukla R; Department of Human DNA Variability, Pfizer/University of Granada and Andalusian Regional Government Center for Genomics and Oncology (GENYO), PTS Granada, 18016 Granada, Spain.
  • Wang J; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, Brisbane, Queensland 4102, Australia.
  • Garcia-Cañadas M; Max-Delbrück-Center for Molecular Medicine, D-13125 Berlin, Germany.
  • Lopez-Ruiz C; Department of Human DNA Variability, Pfizer/University of Granada and Andalusian Regional Government Center for Genomics and Oncology (GENYO), PTS Granada, 18016 Granada, Spain.
  • Gerhardt DJ; Department of Human DNA Variability, Pfizer/University of Granada and Andalusian Regional Government Center for Genomics and Oncology (GENYO), PTS Granada, 18016 Granada, Spain.
  • Sebe A; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, Brisbane, Queensland 4102, Australia.
  • Grabundzija I; Division of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225 Langen, Germany.
  • Merkert S; Max-Delbrück-Center for Molecular Medicine, D-13125 Berlin, Germany.
  • Gerdes P; Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery; REBIRTH, Cluster of Excellence, Hannover Medical School, D-30625 Hannover, Germany.
  • Pulgarin JA; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, Brisbane, Queensland 4102, Australia.
  • Bock A; Department of Human DNA Variability, Pfizer/University of Granada and Andalusian Regional Government Center for Genomics and Oncology (GENYO), PTS Granada, 18016 Granada, Spain.
  • Held U; Division of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225 Langen, Germany.
  • Witthuhn A; Division of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225 Langen, Germany.
  • Haase A; Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery; REBIRTH, Cluster of Excellence, Hannover Medical School, D-30625 Hannover, Germany.
  • Sarkadi B; Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery; REBIRTH, Cluster of Excellence, Hannover Medical School, D-30625 Hannover, Germany.
  • Löwer J; Department of Biophysics and Radiation Biology, Semmelweis University, H-1094 Budapest, Hungary.
  • Wolvetang EJ; Division of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225 Langen, Germany.
  • Martin U; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland 4072, Australia.
  • Ivics Z; Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery; REBIRTH, Cluster of Excellence, Hannover Medical School, D-30625 Hannover, Germany.
  • Izsvák Z; Division of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225 Langen, Germany.
  • Garcia-Perez JL; Max-Delbrück-Center for Molecular Medicine, D-13125 Berlin, Germany.
  • Faulkner GJ; Department of Human DNA Variability, Pfizer/University of Granada and Andalusian Regional Government Center for Genomics and Oncology (GENYO), PTS Granada, 18016 Granada, Spain.
  • Schumann GG; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, Brisbane, Queensland 4102, Australia.
Nat Commun ; 7: 10286, 2016 Jan 08.
Article em En | MEDLINE | ID: mdl-26743714
ABSTRACT
Human induced pluripotent stem cells (hiPSCs) are capable of unlimited proliferation and can differentiate in vitro to generate derivatives of the three primary germ layers. Genetic and epigenetic abnormalities have been reported by Wissing and colleagues to occur during hiPSC derivation, including mobilization of engineered LINE-1 (L1) retrotransposons. However, incidence and functional impact of endogenous retrotransposition in hiPSCs are yet to be established. Here we apply retrotransposon capture sequencing to eight hiPSC lines and three human embryonic stem cell (hESC) lines, revealing endogenous L1, Alu and SINE-VNTR-Alu (SVA) mobilization during reprogramming and pluripotent stem cell cultivation. Surprisingly, 4/7 de novo L1 insertions are full length and 6/11 retrotransposition events occurred in protein-coding genes expressed in pluripotent stem cells. We further demonstrate that an intronic L1 insertion in the CADPS2 gene is acquired during hiPSC cultivation and disrupts CADPS2 expression. These experiments elucidate endogenous retrotransposition, and its potential consequences, in hiPSCs and hESCs.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Elementos Nucleotídeos Longos e Dispersos / Elementos Alu / Proliferação de Células / Células-Tronco Embrionárias / Reprogramação Celular / Células-Tronco Pluripotentes Induzidas Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Elementos Nucleotídeos Longos e Dispersos / Elementos Alu / Proliferação de Células / Células-Tronco Embrionárias / Reprogramação Celular / Células-Tronco Pluripotentes Induzidas Idioma: En Ano de publicação: 2016 Tipo de documento: Article